ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 81 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,529,000 | +57.5% | 742,666 | +33.3% | 0.54% | +66.6% |
| Q2 2021 | $9,857,000 | -35.5% | 557,210 | -10.7% | 0.32% | -36.4% |
| Q1 2021 | $15,293,000 | -7.5% | 624,210 | +27.9% | 0.51% | -11.7% |
| Q4 2020 | $16,527,000 | +111.5% | 488,234 | +56.2% | 0.58% | +66.2% |
| Q3 2020 | $7,815,000 | +37.0% | 312,483 | +84.7% | 0.35% | +28.6% |
| Q2 2020 | $5,706,000 | – | 169,168 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,007,576 | $25,199,000 | 12.12% |
| Svennilson Peter | 4,768,181 | $119,252,000 | 9.73% |
| EcoR1 Capital, LLC | 2,642,218 | $66,082,000 | 4.71% |
| Orbimed Advisors | 2,921,967 | $73,078,000 | 0.92% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 312,483 | $7,815,000 | 0.35% |
| EMERALD ADVISERS, LLC | 324,582 | $8,118,000 | 0.33% |
| Casdin Capital, LLC | 251,515 | $6,290,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 995,382 | $24,895,000 | 0.24% |
| Artal Group S.A. | 142,500 | $3,564,000 | 0.09% |
| Alyeska Investment Group, L.P. | 161,585 | $4,041,000 | 0.06% |